EA201690185A1 - Анализ timp2, обладающий улучшенной эффективностью в биологическом образце - Google Patents

Анализ timp2, обладающий улучшенной эффективностью в биологическом образце

Info

Publication number
EA201690185A1
EA201690185A1 EA201690185A EA201690185A EA201690185A1 EA 201690185 A1 EA201690185 A1 EA 201690185A1 EA 201690185 A EA201690185 A EA 201690185A EA 201690185 A EA201690185 A EA 201690185A EA 201690185 A1 EA201690185 A1 EA 201690185A1
Authority
EA
Eurasian Patent Office
Prior art keywords
timp2
analysis
owning
biological sample
improved efficiency
Prior art date
Application number
EA201690185A
Other languages
English (en)
Inventor
Рави А. Виджаендран
Сриватса Венкатасуббарао
Original Assignee
Астьют Медикал, Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Астьют Медикал, Инк. filed Critical Астьют Медикал, Инк.
Publication of EA201690185A1 publication Critical patent/EA201690185A1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/38—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against protease inhibitors of peptide structure
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/577—Immunoassay; Biospecific binding assay; Materials therefor involving monoclonal antibodies binding reaction mechanisms characterised by the use of monoclonal antibodies; monoclonal antibodies per se are classified with their corresponding antigens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/81—Protease inhibitors
    • G01N2333/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • G01N2333/8146—Metalloprotease (E.C. 3.4.24) inhibitors, e.g. tissue inhibitor of metallo proteinase, TIMP

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

В настоящем изобретении предложены иммуноанализы TIMP2 с улучшенной клинической эффективностью, в частности, при применении для оценки поражений почек. В основе указанных иммуноанализов лежит выбор и применение антител и пар антител, демонстрирующих улучшенные аналитические рабочие характеристики при применении в комплексных клинических образцах, таких как биологические жидкости, и, в частности, при применении в формате экспресс-анализа, таком как устройства, основанные на анализе растекания образца.
EA201690185A 2013-08-07 2014-08-07 Анализ timp2, обладающий улучшенной эффективностью в биологическом образце EA201690185A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361863073P 2013-08-07 2013-08-07
PCT/US2014/050195 WO2015021308A1 (en) 2013-08-07 2014-08-07 Assays for timp2 having improved performance in biological samples

Publications (1)

Publication Number Publication Date
EA201690185A1 true EA201690185A1 (ru) 2016-07-29

Family

ID=52461941

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201690185A EA201690185A1 (ru) 2013-08-07 2014-08-07 Анализ timp2, обладающий улучшенной эффективностью в биологическом образце

Country Status (12)

Country Link
US (2) US9879091B2 (ru)
EP (2) EP3030582A4 (ru)
JP (1) JP2016528236A (ru)
KR (1) KR20160039682A (ru)
CN (1) CN105531291A (ru)
AU (1) AU2014305883A1 (ru)
BR (1) BR112016002685A2 (ru)
CA (1) CA2920521A1 (ru)
EA (1) EA201690185A1 (ru)
HK (1) HK1222180A1 (ru)
MX (1) MX2016001573A (ru)
WO (1) WO2015021308A1 (ru)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2012506537A (ja) 2008-10-21 2012-03-15 アスチュート メディカル，インコーポレイテッド 腎損傷および腎不全の診断および予後のための方法および組成物
ES2592386T3 (es) 2009-12-20 2016-11-29 Astute Medical, Inc. Métodos y composiciones para el diagnóstico y pronóstico de lesión renal e insuficiencia renal
EP3339860A1 (en) 2010-06-23 2018-06-27 Astute Medical, Inc. Methods and compositions for diagnosis and prognosis of renal injury and renal failure
ES2933570T3 (es) 2011-12-08 2023-02-10 Astute Medical Inc Métodos y composiciones para el diagnóstico y el pronóstico de una lesión renal y de una insuficiencia renal
ES2681955T3 (es) 2013-01-17 2018-09-17 Astute Medical, Inc. Métodos y composiciones para el diagnóstico y pronóstico de lesión renal e insuficiencia renal
CN105917229B (zh) 2013-12-03 2019-04-26 阿斯图特医药公司 用于肾损伤和肾衰竭的诊断和预后的方法和组合物
US11243202B2 (en) 2015-04-09 2022-02-08 Astute Medical, Inc. Methods and compositions for diagnosis and prognosis of renal injury and renal failure
WO2017117490A1 (en) * 2015-12-30 2017-07-06 Bio-Rad Laboratories, Inc. Droplet assay system with automatic calibration
JP2019523889A (ja) 2016-06-06 2019-08-29 アスチュート メディカル，インコーポレイテッド インスリン様増殖因子結合タンパク質７およびメタロプロテアーゼ２の組織阻害剤を使用する急性腎臓傷害の管理
US12006351B2 (en) * 2016-06-30 2024-06-11 The Research Foundation For The State University Of New York Compositions and methods for modifying activity of extracellular MMP-2
ES2908239T3 (es) * 2016-10-28 2022-04-28 Astute Medical Inc Uso de anticuerpos contra timp-2 para la mejora de la función renal
CN110431422A (zh) 2017-02-06 2019-11-08 机敏医药股份有限公司 用于肾损伤和肾衰竭的诊断和预后的方法和组合物
EP3606554A4 (en) * 2017-04-05 2020-12-09 Astute Medical, Inc. ASSAYS FOR TIMP2 WITH IMPROVED EFFICIENCY IN BIOLOGICAL SAMPLES
SG11202011502VA (en) 2018-05-24 2020-12-30 Renibus Therapeutics Inc Methods of treating patients at risk for renal injury and renal failure

Family Cites Families (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US459004A (en) 1891-09-08 Box for steaming cops
DE3029579C2 (de) 1980-08-05 1985-12-12 Boehringer Mannheim Gmbh, 6800 Mannheim Verfahren und Mittel zur Abtrennung von Plasma oder Serum aus Vollblut
US5807715A (en) 1984-08-27 1998-09-15 The Board Of Trustees Of The Leland Stanford Junior University Methods and transformed mammalian lymphocyte cells for producing functional antigen-binding protein including chimeric immunoglobulin
US5223409A (en) 1988-09-02 1993-06-29 Protein Engineering Corp. Directed evolution of novel binding proteins
US5530101A (en) 1988-12-28 1996-06-25 Protein Design Labs, Inc. Humanized immunoglobulins
US5028535A (en) 1989-01-10 1991-07-02 Biosite Diagnostics, Inc. Threshold ligand-receptor assay
US5939272A (en) 1989-01-10 1999-08-17 Biosite Diagnostics Incorporated Non-competitive threshold ligand-receptor assays
US5698671A (en) * 1989-03-21 1997-12-16 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Metalloproteinase peptides
US5413923A (en) 1989-07-25 1995-05-09 Cell Genesys, Inc. Homologous recombination for universal donor cells and chimeric mammalian hosts
US5859205A (en) 1989-12-21 1999-01-12 Celltech Limited Humanised antibodies
JP3068180B2 (ja) 1990-01-12 2000-07-24 アブジェニックス インコーポレイテッド 異種抗体の生成
US5922615A (en) 1990-03-12 1999-07-13 Biosite Diagnostics Incorporated Assay devices comprising a porous capture membrane in fluid-withdrawing contact with a nonabsorbent capillary network
US5166051A (en) 1990-08-08 1992-11-24 Genesis Labs, Inc. Membranes, membrane overlays for exclusion of erythrocytes, and method for immunoassay of whole blood analytes
US5625126A (en) 1990-08-29 1997-04-29 Genpharm International, Inc. Transgenic non-human animals for producing heterologous antibodies
ATE158021T1 (de) 1990-08-29 1997-09-15 Genpharm Int Produktion und nützung nicht-menschliche transgentiere zur produktion heterologe antikörper
US5814318A (en) 1990-08-29 1998-09-29 Genpharm International Inc. Transgenic non-human animals for producing heterologous antibodies
US5545806A (en) 1990-08-29 1996-08-13 Genpharm International, Inc. Ransgenic non-human animals for producing heterologous antibodies
US5661016A (en) 1990-08-29 1997-08-26 Genpharm International Inc. Transgenic non-human animals capable of producing heterologous antibodies of various isotypes
US5633425A (en) 1990-08-29 1997-05-27 Genpharm International, Inc. Transgenic non-human animals capable of producing heterologous antibodies
CA2072758A1 (en) 1990-09-14 1992-03-15 Kenneth Francis Buechler Antibodies to complexes of ligand receptors and ligands and their utility in ligand-receptor assays
US5955377A (en) 1991-02-11 1999-09-21 Biostar, Inc. Methods and kits for the amplification of thin film based assays
DE69228682T2 (de) 1991-04-10 1999-07-01 Biosite Diagnostics Inc., San Diego, Calif. "crosstalk"- oder übersprech-inhibitoren und ihre verwendung
DE69231382T2 (de) 1991-04-12 2001-01-25 Biosite Diagnostics Inc., San Diego Neue konjugate und testverfahren für die gleichzeitige bestimmung von multiplen liganden
US6797492B2 (en) 1991-05-17 2004-09-28 Merck & Co., Inc. Method for reducing the immunogenicity of antibody variable domains
WO1994004679A1 (en) 1991-06-14 1994-03-03 Genentech, Inc. Method for making humanized antibodies
WO1992022653A1 (en) 1991-06-14 1992-12-23 Genentech, Inc. Method for making humanized antibodies
US6143576A (en) 1992-05-21 2000-11-07 Biosite Diagnostics, Inc. Non-porous diagnostic devices for the controlled movement of reagents
US6019944A (en) 1992-05-21 2000-02-01 Biosite Diagnostics, Inc. Diagnostic devices and apparatus for the controlled movement of reagents without membranes
US5494829A (en) 1992-07-31 1996-02-27 Biostar, Inc. Devices and methods for detection of an analyte based upon light interference
US5824799A (en) 1993-09-24 1998-10-20 Biosite Diagnostics Incorporated Hybrid phthalocyanine derivatives and their uses
US6562596B1 (en) * 1993-10-06 2003-05-13 Amgen Inc. Tissue inhibitor of metalloproteinase type three (TIMP-3) composition and methods
DE69637481T2 (de) 1995-04-27 2009-04-09 Amgen Fremont Inc. Aus immunisierten Xenomäusen stammende menschliche Antikörper gegen IL-8
AU2466895A (en) 1995-04-28 1996-11-18 Abgenix, Inc. Human antibodies derived from immunized xenomice
US6391265B1 (en) 1996-08-26 2002-05-21 Biosite Diagnostics, Inc. Devices incorporating filters for filtering fluid samples
US6113855A (en) 1996-11-15 2000-09-05 Biosite Diagnostics, Inc. Devices comprising multiple capillarity inducing surfaces
KR20080059467A (ko) 1996-12-03 2008-06-27 아브게닉스, 인크. 복수의 ｖｈ 및 ｖｋ 부위를 함유하는 사람 면역글로불린유전자좌를 갖는 형질전환된 포유류 및 이로부터 생성된항체
US6045899A (en) 1996-12-12 2000-04-04 Usf Filtration & Separations Group, Inc. Highly assymetric, hydrophilic, microfiltration membranes having large pore diameters
US5947124A (en) 1997-03-11 1999-09-07 Biosite Diagnostics Incorporated Diagnostic for determining the time of a heart attack
US6057098A (en) 1997-04-04 2000-05-02 Biosite Diagnostics, Inc. Polyvalent display libraries
ES2323540T3 (es) * 1997-07-16 2009-07-20 Charm Sciences Inc. Metodo para detectar la presencia de un analito residual en una muestra.
AU3185199A (en) * 1998-03-16 1999-10-11 Quidel Corporation Immunoassay device and method
US7214542B2 (en) * 2003-01-30 2007-05-08 Michael Hutchinson Method of processing assay test results
WO2004096832A2 (en) 2003-04-29 2004-11-11 Children's Medical Center Corporation Novel antiangiogenic peptides
CN1833169A (zh) * 2003-08-11 2006-09-13 协和梅迪克斯株式会社 测量对象物测量器具、测量装置和测量方法
EP1774338B1 (en) * 2004-07-28 2009-06-03 F.Hoffmann-La Roche Ag Timp-2 as target/marker of beta cell failure
US7485468B2 (en) * 2004-10-15 2009-02-03 Galapagos Bv Molecular targets and compounds, and methods to identify the same, useful in the treatment of joint degenerative and inflammatory diseases
WO2007048100A2 (en) * 2005-10-18 2007-04-26 The Government Of The United States, As Represented By The Secretary Of Health & Human Services Angio-inhibitory peptides derived from human timp-2
JP2012506537A (ja) 2008-10-21 2012-03-15 アスチュート メディカル，インコーポレイテッド 腎損傷および腎不全の診断および予後のための方法および組成物
US8900881B2 (en) * 2008-12-30 2014-12-02 Jin Po Lee Quantitative analyte assay device and method
ES2592386T3 (es) 2009-12-20 2016-11-29 Astute Medical, Inc. Métodos y composiciones para el diagnóstico y pronóstico de lesión renal e insuficiencia renal
CA2794721A1 (en) * 2010-03-31 2011-10-13 Sekisui Medical Co., Ltd. Assay utilizing immunochromatography, immunochromatographic test strip, and assay reagent kit for immunochromatography

Also Published As

Publication number Publication date
MX2016001573A (es) 2016-09-07
US20160297893A1 (en) 2016-10-13
HK1222180A1 (zh) 2017-06-23
EP3030582A4 (en) 2017-05-17
KR20160039682A (ko) 2016-04-11
US20180162953A1 (en) 2018-06-14
EP3617234A1 (en) 2020-03-04
BR112016002685A2 (pt) 2018-01-30
EP3030582A1 (en) 2016-06-15
AU2014305883A1 (en) 2016-02-25
CA2920521A1 (en) 2015-02-12
WO2015021308A1 (en) 2015-02-12
US9879091B2 (en) 2018-01-30
JP2016528236A (ja) 2016-09-15
US10457744B2 (en) 2019-10-29
CN105531291A (zh) 2016-04-27

Similar Documents

Publication Publication Date Title
EA201690185A1 (ru) Анализ timp2, обладающий улучшенной эффективностью в биологическом образце
EA201690731A1 (ru) Анализ igfbp7, имеющий улучшенную характеристику в биологических образцах
CL2015002756A1 (es) Moléculas fc biespecíficas
AR093984A1 (es) Anticuerpos que se unen a ligando 1 de muerte programada (pd-l1) humano
MX2018007630A (es) Anticuerpos contra la metaloproteinasa de matriz 9.
TR201900160T4 (tr) Bir anti-ilaç antikoru varlığının veya miktarının saptanmasına yönelik analizler.
TR201818881T4 (tr) Sinyal Amplifikasyonu İmmünodeneyleri
EP4024029A3 (en) Systems and methods for sample use maximization
EA201491686A1 (ru) Мультиспецифические антигенсвязывающие молекулы и их применения
EA201591376A1 (ru) Конструкции антител к cdh19 и cd3
BR112015023338A8 (pt) dispositivo e métodos para a coleta de uma amostra de fluido corporal
EA201790664A1 (ru) Антитела против мезотелина и иммуноконъюгаты
EA201201420A1 (ru) Система и устройство для выполнения анализа образцов
IN2014DN08011A (ru)
EA201201016A1 (ru) Антидоты антикоагулянтов
AR089752A1 (es) Anticuerpos anti-lrp5 y metodos de uso
EA201690213A1 (ru) Композиции и способ лечения связанных с комплементом состояний
EA201792289A1 (ru) Способы обнаружения агглютинации и композиции для их осуществления
EA201400873A1 (ru) Механическая промывка и измерительный прибор для выполнения анализов
EA201400447A1 (ru) АНТИТЕЛА К CD1d
EA201690992A1 (ru) Антитела, специфичные к fcrn
PE20160657A1 (es) Composiciones y metodos para identificar un riesgo de cancer en un sujeto
EA201991506A1 (ru) Системы и способы для тестирования и скрининга с использованием связанных с соединениями субстратов
EA201500377A1 (ru) Способ обнаружения анализируемого вещества и определение его концентрации с использованием намагничиваемых гранул
RU2012130218A (ru) Микрофлюидная система для проведения иммуноанализа